Parkman Healthcare Partners LLC Vera Therapeutics, Inc. Transaction History

Parkman Healthcare Partners LLC

  • $708 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$17.8 - $28.06 $383,679 - $604,833
-21,555 Closed
0 $0
Q4 2021

Feb 11, 2022
SELL
$15.01 - $35.8 $61,285 - $146,171
-4,083 Reduced 15.93%
21,555 $576,000
Q3 2021

Nov 12, 2021
SELL
$13.71 - $30.6 $685,500 - $1.53 Million
-50,000 Reduced 66.1%
25,638 $445,000
Q2 2021

Aug 13, 2021
BUY
$11.5 - $19.97 $869,837 - $1.51 Million
75,638 New
75,638 $1 Million

Others Institutions Holding VERA

# of Institutions
190
Shares Held
56M
Call Options Held
134K
Put Options Held
156K
View Full List

About Vera Therapeutics, Inc.

VERA Quotes by TradingView
  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $977M
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email